PASG
Passage Bio Inc
NASDAQ: PASG · HEALTHCARE · BIOTECHNOLOGY
$5.11
-4.49% today
Updated 2026-04-30
Market cap
$18.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.35
Dividend yield
—
52W range
$5 – $20
Volume
0.1M
Passage Bio Inc (PASG) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-114.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-1945.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+9.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+22.5%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $-4.09 | -46.3% | $8.78 | $8.44 | -3.9% |
| 2025-11-10 | $-2.44 | -1120.0% | $6.29 | $7.70 | +22.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-2.80 | $-4.09 | -46.3% | — | — |
| 2025-09-30 | $-0.20 | $-2.44 | -1120.0% | — | — |
| 2025-06-30 | $-0.20 | $-2.96 | -1365.3% | — | — |
| 2025-03-31 | $-0.22 | $-0.25 | -12.0% | — | — |
| 2024-12-31 | $-0.20 | $-0.20 | +0.0% | $3.21M | -45.7% |
| 2024-09-30 | $-0.23 | $-0.24 | -2.4% | — | — |
| 2024-06-30 | $-0.31 | $-0.26 | +16.1% | — | — |
| 2024-03-31 | $-0.36 | $-0.30 | +16.7% | — | — |
| 2023-12-31 | $-0.40 | $-0.30 | +25.0% | $5.91M | — |
| 2023-09-30 | $-0.46 | $-0.49 | -6.5% | — | — |
| 2023-06-30 | $-0.48 | $-0.44 | +8.3% | — | — |
| 2023-03-31 | $-0.50 | $-0.63 | -26.0% | — | — |
Frequently asked questions
Has Passage Bio Inc beaten earnings estimates?
Passage Bio Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -114.6% over the last 4 quarters.
How does PASG stock react to earnings?
PASG stock has moved an average of +9.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.